Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United States

Summary: There are currently hundreds of businesses across the United States offering direct-to-consumer stem cell treatments that have not been through regulatory approval by the Food and Drug Administration (FDA). Here, we provide a detailed characterization of nearly 170 stem cell businesses oper...

Full description

Bibliographic Details

Published in:	Stem Cell Reports
Main Authors:	Emma K. Frow, David A. Brafman, Anna Muldoon, Logan Krum, Paige Williams, Bryson Becker, John P. Nelson, Ashley Pritchett
Format:	Article
Language:	English
Published:	Elsevier 2019-08-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S221367111930253X